Common Betta Fish Diseases and How to Treat Them

Betta fish (Betta splendens) are among the most popular aquarium species worldwide, prized for their vivid colours (or colours) and unique personalities. However, they are also predisposed to a range of infectious and non‑infectious diseases, many of which stem from suboptimal water quality, stress, or inadequate nutrition. Early recognition and evidence‑based treatment are essential to improving outcomes. This article provides a clinically detailed, publication‑grade overview of the most common betta diseases, including fin rot, ich, dropsy, and swim bladder disorder, with a strong emphasis on prevention through water quality management.

Quick Q&A

• Question: How can I treat fin rot in my betta fish?
  Answer: Fin rot is typically caused by bacteria such as Aeromonas or Pseudomonas. Treatment involves improving water quality, removing any decaying plant matter, and administering broad-spectrum antibiotics like erythromycin or tetracycline. In severe cases, medicated baths with nitrofurazone may be necessary.

• Question: What is the best way to prevent ich in betta fish?
  Answer: Ich (white spot disease) is caused by the parasite Ichthyophthirius multifiliis. Prevention relies on maintaining stable water temperature (26–28°C), avoiding sudden stress, and quarantining new fish or plants for at least 14 days. Early treatment with heat (gradually raising temperature to 30°C) and aquarium salt (1–2 g/L) is usually effective.

• Question: Can dropsy be cured in betta fish?
  Answer: Dropsy is a symptom of internal bacterial infection leading to fluid retention. Cure depends on early detection. Isolate the fish, add Epsom salt (1–3 g/L) to reduce swelling, and treat with a broad-spectrum antibiotic effective against Gram‑negative bacteria (e.g., kanamycin or oxytetracycline). Unfortunately, advanced cases often have a poor prognosis.

• Question: Why does my betta fish have swim bladder problems?
  Answer: Swim bladder disorder can result from overfeeding, constipation, poor water quality, or infection. Treatment starts with fasting for 24–48 hours, then offering a blanched pea or daphnia. If no improvement, consider a antibacterial therapy. Ensuring good water quality is crucial for prevention.

Understanding Betta Fish Health

The health of a betta is directly linked to its environment. In aquaculture and home aquaria, stress is the primary predisposing factor for disease [36]. Stressors include abrupt temperature changes, high ammonia or nitrite levels, overcrowding, and poor nutrition. Although much of the research into host‑pathogen interactions has been performed in mammals, the fundamental principles of immunity and inflammation apply across vertebrates [13]. For instance, macrophage‑driven clearance of pathogens and tissue repair, as demonstrated in murine liver regeneration models, share evolutionary conserved pathways that are also active in teleost fish [13]. Similarly, the role of inflammatory cytokines like IL‑6 in modulating the immune response, seen in rheumatoid arthritis studies, is recapitulated in fish during bacterial infections [37].

Therefore, a holistic approach that addresses environmental quality, nutrition, and early intervention remains the cornerstone of betta medicine.

Fin Rot

Aetiology and Presentation

Fin rot is one of the most commonly encountered diseases in captive bettas. It is primarily caused by Gram‑negative bacteria, most frequently Aeromonas spp. and Pseudomonas spp. [36]. A recent case series highlighted the emerging importance of Aeromonas dhakensis, which can express carbapenem resistance and is often misidentified in routine diagnostics [36]. The disease begins as a fraying or discolouration of the fin edges, progressing to erosion of the fin tissue. In advanced cases, the base of the fin may become inflamed (reddened) and the fish may become lethargic.

Risk factors include high organic load (excess food, decaying plants), low water temperature, and poor water quality.

Treatment

First‑line therapy is improvement of hygiene and water parameters. Perform a 50% water change and vacuum the substrate. Remove any sharp decorations that could cause mechanical damage.

Second, administer a broad‑spectrum antibiotic. Suitable choices include erythromycin, tetracycline, or nitrofurazone. These are available as aquarium preparations. In cases where bacterial resistance is suspected, culture and sensitivity testing (by an aquatic veterinarian) is advisable [23]. The rising prevalence of multidrug‑resistant strains in aquatic environments underscores the need for judicious antibiotic use [23].

For mild cases, tannin‑based treatments (e.g., Indian almond leaves) can provide a supportive antiseptic effect, though they are not curative alone.

Prevention

Maintain ammonia and nitrite at 0 mg/L, nitrate below 20 mg/L, and a stable temperature of 26–28°C. Provide a varied diet to support fin health. Quarantine any new additions.

Ich (White Spot Disease)

Aetiology and Presentation

Ich is caused by the ciliated parasite Ichthyophthirius multifiliis. The parasite has a life cycle that includes a free‑swimming stage (tomite) that is vulnerable to treatment, and an encysted stage within the fish's skin that is refractory. Affected fish develop small white spots (up to 1 mm) resembling grains of salt, often accompanied by increased mucus production, flashing (rubbing against objects), and respiratory distress.

Treatment

Heat therapy is often effective: slowly raise the water temperature to 30–31°C over 24–48 hours (ensuring adequate aeration) and maintain for 5–7 days. Simultaneously, add aquarium salt at 1–2 g/L to disrupt the parasite’s osmotic balance. For refractory cases, use formalin‑based medications (e.g., 0.015 mL/L of 37% formalin) or malachite green, but these must be used with caution as they can harm the fish’s gills and beneficial filter bacteria. Photodynamic therapy using nanoparticles has been explored in other biofilm models [16] and may hold future potential for parasitic diseases, but is not yet standard.

Prevention

Quarantine all new fish and plants. Avoid rapid temperature fluctuations. Maintain good water quality.

Dropsy

Aetiology and Presentation

Dropsy is not a specific disease but a clinical sign of internal bacterial infection, usually by Aeromonas or Mycobacterium spp. It results in renal and hepatic failure, leading to fluid accumulation in the coelomic cavity. The fish exhibits a swollen abdomen, raised scales (pinecone appearance), and often exophthalmos (pop‑eye). The condition is frequently fatal if not treated early.

Treatment

Immediate isolation is essential. Add Epsom salt (magnesium sulfate) at a concentration of 1–3 g/L to the hospital tank to draw out excess fluid osmotically. Antibiotic therapy should target Gram‑negative bacteria; kanamycin, oxytetracycline, or enrofloxacin are commonly used. Note that many over‑the‑counter “dropsy treatments” are ineffective. Systemic infections may require a combination therapy approach, analogous to the synergistic use of mesenchymal stem cells and botanical compounds seen in mammalian models [37]. In fish, supportive care, such as pristine water and easily digestible foods, can improve the chance of recovery.

Prognosis

The prognosis is guarded. If the fish ceases eating or shows severe scale protrusion over more than 50% of the body, euthanasia should be considered on welfare grounds.

Swim Bladder Disorder

Aetiology and Presentation

Swim bladder disorder (SBD) in bettas manifests as buoyancy problems, the fish may float uncontrollably, sink to the bottom, or swim in a tilted position. Causes are multifactorial: constipation (from dry, floating foods), over‑inflation of the swim bladder, bacterial infection, or physical compression due to obesity or egg‑binding. In some cases, it is idiopathic.

Treatment

Step 1: Fast the fish for 24–48 hours.
Step 2: Offer a blanched, shelled pea (or daphnia) to relieve constipation.
Step 3: If no improvement, consider a broad‑spectrum antibiotic bath for 5–7 days, as bacterial involvement is possible.
Step 4: Ensure water depth is not excessive; a shallower hospital tank (15–20 cm) reduces pressure on the swim bladder.

For chronic or non‑responsive cases, consult an aquatic veterinarian. Some cases may be irreversible if due to structural deformity.

Prevention via Water Quality

The adage “prevention is better than cure” is particularly apt for aquarium fish. The majority of betta diseases can be avoided through rigorous water quality management.

Key Parameters

• Ammonia (NH₃): 0 mg/L
• Nitrite (NO₂⁻): 0 mg/L
• Nitrate (NO₃⁻): < 20 mg/L (ideally < 10 mg/L)
• pH: 6.5–7.5 (stable)
• Temperature: 26–28°C
• Dissolved oxygen: > 5 mg/L

The nitrogen cycle must be fully established before introducing fish. Regular testing (at least weekly) using liquid test kits is recommended.

Water Change Protocol

Perform partial water changes of 25–50% every 5–7 days for a cycled tank. Use a dechlorinator. For small bowls or unfiltered tanks, more frequent changes (e.g., 50% every 2–3 days) are necessary.

Additional Measures

• Avoid overstocking; a single betta in a 10‑L tank is the absolute minimum.
• Use biological filtration to support the cycle.
• Provide environmental enrichment (plants, hiding spots) to reduce stress.

Stress, as research in other taxa has shown, directly impairs immune function and increases susceptibility to infection [1]. In human populations, environmental stressors correlate with higher rates of opportunistic infections [1]; the same principle applies to fish.

General Treatment Principles and When to Consult a Veterinarian

While many minor ailments can be managed at home, veterinary consultation is warranted when:

• The fish stops eating for more than 2 days.
• There are signs of systemic infection (e.g., dropsy, persistent lethargy).
• Lesions or parasites do not respond to first‑line treatments within 5 days.
• There is difficulty swimming or breathing.

Aquatic veterinarians (registered through organisations such as the World Aquatic Veterinary Medical Association (WAVMA)) can perform diagnostics (e.g., skin scrapes, bacterial culture) and prescribe more potent medications that are not available over the counter. In regions with veterinary oversight (e.g., Europe under EMA guidelines, Australia under DAFF), the use of antibiotics without a prescription is prohibited to combat antimicrobial resistance [23]. Responsible medication use is essential for both fish welfare and environmental health.

Conclusion

Betta fish are resilient but require attentive care. The most common diseases, fin rot, ich, dropsy, and swim bladder disorder, are largely preventable through stable, high‑quality water conditions and a balanced diet. Early recognition and evidence‑based treatment, including appropriate antimicrobial therapy and supportive care, can greatly improve outcomes. When in doubt, seek the advice of an aquatic veterinarian. By combining rigorous husbandry with a thoughtful treatment approach, keepers can enjoy the beauty and companionship of healthy bettas for years.

References

[1] Ibrahim J, Abdilahi S, Osman M. Prevalence and determinants of anemia among people living with HIV receiving antiretroviral therapy in public health facilities in Jigjiga, Ethiopia. AIDS Res Ther. 2026.
[2] Liang X, Li Y, Tang Z, et al. Mesenchymal stem cell-derived microvesicles confer protection against rheumatoid arthritis-associated interstitial lung disease. Stem Cell Res Ther. 2026.
[3] Yu X, Lu Y, Tan Z, et al. Targeting microglial circMBNL1 unlocks a novel nanomedicine therapeutic strategy for major depressive disorder. J Nanobiotechnology. 2026.
[4] Liang Y, Wu K, Pan L, et al. Tertiary lymphoid structures in breast cancer: Mechanistic insights, subtype-specific patterns, and therapeutic implications. World J Surg Oncol. 2026.
[5] Liu Y, Chen S, Xu J, et al. Macrophage-derived CTSZ promotes prostate cancer progression via αVβ3 integrin-mediated activation of the AKT/FOXO1/JUNB signaling axis. Cancer Cell Int. 2026.
[6] Wu Q, Feng Q, Liu Y, et al. Relationship between nursing notes sentiment scores and length of hospital stay in elderly knee osteoarthritis patients undergoing total knee arthroplasty: a retrospective observational study. BMC Nurs. 2026.
[7] Yang SS, Zhang LN, He Y, et al. Multimodal deep learning-based prediction of radiation-induced temporal lobe injury via anatomical imaging and spatial dose: A multicenter study. BMC Med. 2026.
[8] Kim G, Lee J, Park JH, et al. Multistage nanomedicine engineering to overcome sequential barriers to glioblastoma treatment: a review. J Nanobiotechnology. 2026.
[9] Wang W, Zhou L, Wang J, et al. Integrative analysis of SLFN11-related DEGs reveals novel biomarkers for cisplatin sensitivity and immune modulation in colorectal cancer. Cancer Cell Int. 2026.
[10] Vigiano Benedetti V, Conte F, Santoni D, et al. Single-cell profiling reveals a novel CAF subpopulation linking stromal heterogeneity to immune suppression in breast cancer subtypes. J Transl Med. 2026.
[11] Wang H, Hao J, Su Y, et al. Association of adjuvant somatostatin analogue therapy with disease-free survival in patients with gastroenteropancreatic neuroendocrine tumours: a Chinese multi-institutional propensity score matched and weighted analysis (CASSANET-GEP). BMC Med. 2026.
[12] Atalla AI, Abbas NH, Sabet NE, et al. CBCT assessment of maxillary molar distalization and root length changes during clear aligner therapy. BMC Oral Health. 2026.
[13] Starkey Lewis PJ, Cartwright JA, Campana L, et al. Administration of human macrophage colony-stimulating factor-mFc fusion protein increases macrophage phagocytic capacity and stimulates liver regeneration in mice. J Inflamm (Lond). 2026.
[14] Onishi Y, Tsuji K, Nakanoh H, et al. Educational impact of a simulation-based renal biopsy workshop for medical students during nephrology clerkship. BMC Med Educ. 2026.
[15] Kim H, Yoon J, Noh H, et al. Machine learning for predicting institutionalization and mortality risks among older home care recipients with routinely collected need assessment data: explainable AI for long-term care. BMC Med Inform Decis Mak. 2026.
[16] Partoazar A, Shahabi S, Afrasiabi S. Ethosomal nanocarrier encapsulating curcumin for antimicrobial photodynamic therapy: efficacy analysis against mature Streptococcus mutans biofilm. BMC Oral Health. 2026.
[17] Hounsa E, Reigada I, Assogba P, et al. Traditional medicinal knowledge and diversity of medicinal plants in Benin: a systematic review (2014-2023). BMC Complement Med Ther. 2026.
[18] Deng A, Gan Y, Da J, et al. Early dynamic response on spectral-domain OCT predicts long-term visual outcome in diabetic macular edema treated with aflibercept. BMC Ophthalmol. 2026.
[19] Oudrhiri Safiani M, Zarouali H, El Harrak S, et al. Idiopathic Posterior Reversible Encephalopathy Syndrome (PRES) in a 4-month-old infant: a case report. BMC Neurol. 2026.
[20] Quan X, Wang Z, Zhang L, et al. Pheochromocytoma multisystem crisis presenting with abdominal pain in an adolescent: a case report. BMC Pediatr. 2026.
[21] Atci MM, Erciyestepe M, Erturk K. Efficacy and tolerability of CDK 4/6 inhibitors in HR-positive HER2-negative de novo metastatic breast cancer patients aged ≥ 70 years. BMC Cancer. 2026.
[22] Lins PRG, Uvinha F, Passos FS, et al. Proactive desmopressin for the prevention of serum sodium overcorrection in moderate-to-severe hyponatremia: a systematic review and meta-analysis. BMC Nephrol. 2026.
[23] Shi J, Farid Z, Anjum S, et al. Enhanced antibiofilm activity of ciprofloxacin-loaded quatsomal gel against Multidrug-Resistant Staphylococcus aureus (MRSA). BMC Microbiol. 2026.
[24] Zhang Z, Zhu Y, Zhang G, et al. Gastrointestinal bleeding in patients on venoarterial extracorporeal membrane oxygenation: a multicenter observational study. BMC Gastroenterol. 2026.
[25] Dai T, Xu Z, Wang H, et al. Pharmacokinetics, safety, and efficacy of fuzuloparib in combination with abiraterone acetate and prednisone in patients with metastatic castration-resistant prostate cancer: a phase 1 dose escalation and expansion study. BMC Cancer. 2026.
[26] Tian R, Cui X, Wang L, et al. Pathogen distribution characteristics and risk factors of pulmonary infection associated with immune checkpoint inhibitor therapy in patients with advanced non-small cell lung cancer: a case control study. BMC Infect Dis. 2026.
[27] Wang H, Huang Q, Tian Q, et al. Trends in methicillin-resistant Staphylococcus aureus detection-rates and antibiotic resistance profiles in a cancer hospital from 2015 to 2024. BMC Infect Dis. 2026.
[28] Liu J, Fu B, Zhang Z, et al. Efficacy and safety of treatment strategies for early neurological deterioration after acute ischemic stroke: a network meta-analysis of randomized controlled trials. BMC Neurol. 2026.
[29] Giuliano F, Petta G, Terzaghi M, et al. Integrated plant and rhizosphere response to gadolinium exposure in hydroponically grown tomato plants. BMC Plant Biol. 2026.
[30] Kahtan BE, Azmon R, Hendler K, et al. ANTI-VEGF THERAPY SWITCHING RETINAL DISEASES: Characterizing Clinical Manifestations and Common Involved Genes: ERRATUM. Retina. 2026.
[31] Hardy J, Boullenger J, Cruciani B, et al. A case of successful surgical management of colonic duplication with pygomelia in a 2-month-old dog. J Small Anim Pract. 2026.
[32] Levy EJ, Auyero J. Opportunities and Alliances: The Relational Dynamics of Criminal Collusion in Latin America. Br J Sociol. 2026.
[33] Guo SL, Chen SH, Liu H, et al. [Application of the “2+3” pancreaticojejunostomy in 110 cases of pancreaticoduodenectomy]. Zhonghua Wai Ke Za Zhi. 2026.
[34] Pu N, Liu L. [Repositioning pancreatic surgery and pancreatic surgeons in the era of multidisciplinary treatment for pancreatic cancer]. Zhonghua Wai Ke Za Zhi. 2026.
[35] He J, Li Z. [Reshaping surgical strategies for pancreatic cancer in the era of neoadjuvant therapy: challenges and opportunities]. Zhonghua Wai Ke Za Zhi. 2026.
[36] Verma S, Kuntal K, Deep H, et al. Aeromonas dhakensis as an emerging invasive pathogen: a case series highlighting distinct carbapenem resistance and diagnostic challenge. Eur J Clin Microbiol Infect Dis. 2026.
[37] Su R, Yin S, Gu L, et al. Wenyang Yishen Tongluo prescription synergizes with bone marrow mesenchymal stem cells to alleviate rheumatoid arthritis via inhibiting IL-6. J Mol Histol. 2026.
[38] Chai Y, Shi T, Jiang H, et al. Fibular allograft augmentation shows potential benefits in treating medial column comminuted proximal humeral fractures with osteoporosis: a secondary analysis of a randomized controlled trial. J Orthop Traumatol. 2026.
[39] Chen YM, Lei SH, Liu Y, et al. Photocatalytic low-temperature defluorination of PTFE. Nat Protoc. 2026.
[40] Al Mansoori A, Baig B, Harati R, et al. Safranal improves the anticancer efficacy of sorafenib via transcriptomic reprogramming and metabolomic changes in a rat model of diethylnitrosamine-induced cirrhosis-hepatocellular carcinoma. Naunyn Schmiedebergs Arch Pharmacol. 2026.